THE NEW FRONTIER OF NEUROPROTECTION • INVEST IN TAHIRO TODAY

Invest in the Future of Cognitive Health

Tahiro is redefining wellness with one clear goal: protect the brain.

Backed by science and born from personal experience, our mission is urgent—to help people think sharper, feel more balanced, and proactively support long-term brain health and mental wellbeing. Because protecting the brain shouldn’t start when symptoms appear—it should start now.

Tahiro’s flagship product, Brain Protect™, is the result of years of focused research in nutritional neuroscience. Our formula incorporates clinically studied, neuroprotective compounds—including Nano Omega-5 (punicic acid), full-spectrum pomegranate extract, and validated hemp extract—each chosen for its role in supporting cognitive longevity and neural resilience.

What sets us apart isn’t just what’s inside—it’s how it’s delivered. Our advanced nano-formulation system is engineered for enhanced bioavailability, meaning active compounds reach the brain faster and more efficiently. This isn’t generic supplementation. This is precision-engineered brain care, built for real-world results and supported by emerging clinical insight.

We’re not chasing trends. We’re building a platform grounded in science, transparency, and next-generation formulation—because the future of cognitive health needs more than marketing. It needs solutions that work.

Price per security: $1.50
Minimum investment amount: $450 + 3% investor processing fee

Invest Now

SEC FILINGS • Offering Circular • Investor Education

DOWNLOAD OUR PITCH DECK

FEATURED IN

PROBLEM

The Brain Health Crisis is Escalating

We are on the verge of a global brain health crisis. As life expectancy increases, more people are living long enough to experience significant cognitive decline. What was once rare is now common, and the toll is growing rapidly across every demographic.

Over 50 million people globally suffer from cognitive decline and memory loss.
This number is rapidly increasing with aging populations in nearly every developed nation.
Cognitive degeneration begins earlier than most realize—in our late 20s and 30s—and accelerates through our 40s, 50s, and beyond.

Invest Now

SOLUTION

The New Frontier of Neuroprotection

Tahiro's Breakthrough Solution

Tahiro’s flagship product, Brain Protect™, is a nano-powered supplement scientifically engineered to prevent memory loss and support long-term brain health. It’s backed by robust pre-clinical research and functional hemp-based ingredients.

The Science Behind Tahiro

In-vitro efficacy: Brain Protect™ rescues brain cells in stress-induced environments.
In-vivo studies: Aged mice receiving Brain Protect™ outperformed controls in memory and problem-solving tasks.
Findings from third-party studies were published in peer-reviewed journals, opening the door to $0.5–$1.5M in government-backed clinical research grants.

Tahiro’s patented nanotechnology delivers active ingredients across the blood-brain barrier with superior absorption. This bypasses the digestive system, ensuring faster and more effective nutrient delivery to the brain.

Patent-Pending Innovation

With patents filed in the US, EU, and India, Tahiro is securing strong intellectual property around its core formulas and delivery systems.

PHASE 1

IN-VITRO

In Vitro testing in tissue culture validated the efficacy of the formulation.

PHASE 2

IN-VIVO STUDIES

Aged mice given the Brain Protect formula performed significantly better in memory and problem-solving tests.

PHASE 3

PRE-CLINICAL RESULTS

These promising findings were published recently in a peer-reviewed scientific journal, which will enable us to secure scientific grants ranging from $1/2 to $1.5 million for clinical trials.

MARKET & TRACTION

Scaling a High-Growth Category*

Global cognitive health supplement market: projected to surpass $40B by 2035

Nootropics market expected to reach $73B by 2034

Consumer demand is shifting toward science-backed, non-synthetic, and natural solutions

Exploding Market Opportunity

The global brain health supplement market is growing at a 13.7% CAGR, projected to increase from $9.14B in 2023 to $22.45B by 2030^†.This surge is fueled by:

Aging populations
Increased awareness of neurodegenerative diseases
A shift toward preventative health and wellness

Strong Early Traction

12-Month Revenue Snapshot

$326,539 in product sales (101% YoY growth)
$118,129 in recurring subscription revenue (36% YoY growth)

Customer Base & Subscription Growth

Over 700 active subscribers
Increasing order values and repeat customer metrics
Organic web growth: 793K impressions in the last 6 months

WHY INVEST

Leadership With a Mission

Tahiro is led by a powerhouse team of scientists, health experts, and entrepreneurs:

Dr. Amit Sasson – Co-Founder & President: A holistic life coach and mindfulness practitioner with deep expertise in psychology, cognitive well-being, and metaphysical coaching. He brings a mind-body perspective to Tahiro’s mission, helping shape a vision of brain health that supports mental clarity and emotional balance in the more mature chapters of life.
Avi Palatnik – Co-Founder & CEO: A veteran entrepreneur with 15+ years in startup growth. After discovering a family history and personal risk for Alzheimer’s, Avi committed himself to building practical tools to support long-term brain health.
Neta Golani – Co-Founder & COO: A strategic entrepreneur with UCLA-certified mindfulness training, Neta blends operational focus with a holistic approach to brain health. He helps translate TAHIRO’s scientific vision into scalable, people-centered solutions.
Prof. Oded Shoseyov, Ph. D – Chief Scientist, nanotechnology Innovator: A globally recognized nanobiotechnology and plant molecular biology researcher at The Hebrew University of Jerusalem. With 200+ publications and 14 biotech ventures, he anchors TAHIRO’s scientific vision.
Dr. Ronit Shaltiel-Karyo, Ph. D, MBA – R&D and Innovation Consultant: A neurobiologist and biotech executive with a PhD and MBA, Dr. Ronit previously served as Research Director, Director of Innovation, and Project Manager at Neuroderm (acquired for $1.1B). Her work in protein misfolding and neurodegeneration shapes our translational research strategy.
Supported by top-tier medical advisors and biochemistry specialists

Tahiro is pioneering the future of brain health. With clinically-backed products, innovative nano-delivery, and strong early sales traction, the company is uniquely positioned to lead the next wave of preventative cognitive wellness. This is your chance to invest at a pivotal growth stage in a multi-billion-dollar market.

Invest Now

DOWNLOAD OUR PITCH DECK

FAQs

Why invest in startups?

Regulation CF allows investors to invest in startups and early-growth companies. This is different from helping a company raise money on Kickstarter; with Regulation CF Offerings, you aren’t buying products or merchandise - you are buying a piece of a company and helping it grow.

How much can I invest?

Accredited investors can invest as much as they want. But if you are NOT an accredited investor, your investment limit depends on either your annual income or net worth, whichever is greater. If the number is less than $124,000, you can only invest 5% of it. If both are greater than $124,000 then your investment limit is 10%.

How do I calculate my net worth?

To calculate your net worth, just add up all of your assets and subtract all of your liabilities (excluding the value of the person’s primary residence). The resulting sum is your net worth.

What are the tax implications of an equity crowdfunding investment?

We cannot give tax advice, and we encourage you to talk with your accountant or tax advisor before making an investment.

Who can invest in a Regulation CF Offering?

Individuals over 18 years of age can invest.

What do I need to know about early-stage investing? Are these investments risky?

There will always be some risk involved when investing in a startup or small business. And the earlier you get in the more risk that is usually present. If a young company goes out of business, your ownership interest could lose all value. You may have limited voting power to direct the company due to dilution over time. You may also have to wait about five to seven years (if ever) for an exit via acquisition, IPO, etc. Because early-stage companies are still in the process of perfecting their products, services, and business model, nothing is guaranteed. That’s why startups should only be part of a more balanced, overall investment portfolio.

When will I get my investment back?

The Common Stock (the “Shares”) of Tahiro Inc. (the “Company”) is not publicly traded. As a result, the Shares cannot be easily bought or sold on a public exchange. As an investor in a private company, returns typically occur through one of the following long-term scenarios: The Company is acquired by another business or strategic partner. The Company goes public through an initial public offering (IPO). In either case, investors would generally receive their pro-rata share of the proceeds or gain the ability to sell shares on a public exchange. These types of liquidity events often take 5 to 10 years or longer to materialize, depending on company growth and market conditions. Please note: There is no guarantee of a return. As with all private investments, there is a risk of loss, including the possibility that the company does not achieve a successful exit.

Can I sell my shares?

Shares sold via Regulation Crowdfunding offerings have a one-year lockup period before those shares can be sold under certain conditions.

Exceptions to limitations on selling shares during the one-year lockup period:

In the event of death, divorce, or similar circumstance, shares can be transferred to: - The company that issued the securities - An accredited investor - A family member (child, stepchild, grandchild, parent, stepparent, grandparent, spouse or equivalent, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships)

What happens if a company does not reach their funding target?

If a company does not reach their minimum funding target, all funds will be returned to the investors after the close of the offering.

How can I learn more about a company's offering?

All available disclosure information can be found on the offering pages for our Regulation Crowdfunding offering.

What if I change my mind about investing?

You can cancel your investment at any time, for any reason, until 48 hours prior to a closing occurring. If you’ve already funded your investment and your funds are in escrow, your funds will be promptly refunded to you upon cancellation. To submit a request to cancel your investment please email: [email protected]

How do I keep up with how the company is doing?

At a minimum, the company will be filing with the SEC and posting on its website an annual report, along with certified financial statements. Those should be available 120 days after the fiscal year end. If the company meets a reporting exception, or eventually has to file more reported information to the SEC, the reporting described above may end. If these reports end, you may not continually have current financial information about the company.

What relationship does the company have with DealMaker Securities?

Once an offering ends, the company may continue its relationship with DealMaker Securities for additional offerings in the future. DealMaker Securities’ affiliates may also provide ongoing services to the company. There is no guarantee any services will continue after the offering ends.

INVESTMENT DETAILS

Regulation CF • $1.50 USD • Per Class B Common Stock

Amount-Based Investor Perk Tiers Including Bonus Shares of Class B Common Stock:

$500 to $999
- 20% off first product purchase
- 0% Bonus Shares
$1,000 to $2,499.99
- 1 Full-Size Tahiro Product (Focus, Sleep, or Stress)
- 0% Bonus Shares
$2,500 to $4,999.99
- 3-Month Supply of Brain Protect
- 10% off for 12 months
- 7% Bonus Shares
$5,000 to $9,999.99
- 6-Month Supply of Brain Protect
- 15% off for 12 months
- 10% Bonus Shares

$10,000 to $24,999.99
- 1-Year Supply of Brain Protect
- 20% off for 12 months
- Brain Health Plan Consultation
- Invite to Founder Strategy Session
- 15% Bonus Shares
$25,000 to $49,999.99
- Lifetime 20% Discount
- Premium Wellness Gift Package
- Invite to Exclusive Tahiro Brain Health Session
- 20% Bonus Shares
$50,000.00 and above
- Lifetime 20% Discount
- Premium Wellness Gift Package
- Invite to Exclusive Tahiro Brain Health Session
- Private Dinner with Founders
- 25% Bonus Shares

SOURCES: *Market Size, ^†CAGR

At Tahiro, our mission is not only to create products that improve your brain function ability, but to also share valuable knowledge on how to better maintain a healthy brain. With a balanced routine and our unique formulas, people can improve their everyday life.

Menu

Stay Connected

Disclaimers

DealMaker Securities' info needs to be added to the disclaimer: DealMaker Securities LLC, a registered broker-dealer, and member of FINRA | SIPC, located at 4000 Eagle Point Corporate Drive, Suite 950, Birmingham, AL 35242., is the Intermediary for this offering and is not an affiliate of or connected with the Issuer. Please check our background on FINRA's BrokerCheck.

DealMaker Securities LLC does not make investment recommendations.

DealMaker Securities LLC is NOT placing or selling these securities on behalf of the Issuer.

DealMaker Securities LLC is NOT soliciting this investment or making any recommendations by collecting, reviewing, and processing an Investor's documentation for this investment.

DealMaker Securities LLC conducts Anti-Money Laundering, Identity and Bad Actor Disqualification reviews of the Issuer, and confirms they are a registered business in good standing.

DealMaker Securities LLC is NOT vetting or approving the information provided by the Issuer or the Issuer itself.

Contact information is provided for Investors to make inquiries and requests to DealMaker Securities LLC regarding Regulation CF in general, or the status of such investor’s submitted documentation, specifically. DealMaker Securities LLC may direct Investors to specific sections of the Offering Circular to locate information or answers to their inquiry but does not opine or provide guidance on issuer related matters.

Equity crowdfunding investments in private placements, and start-up investments in particular, are speculative and involve a high degree of risk and those investors who cannot afford to lose their entire investment should not invest in start-ups. Companies seeking startup investment through equity crowdfunding tend to be in earlier stages of development and their business model, products and services may not yet be fully developed, operational or tested in the public marketplace. There is no guarantee that the stated valuation and other terms are accurate or in agreement with the market or industry valuations. Further, investors may receive illiquid and/or restricted stock that may be subject to holding period requirements and/or liquidity concerns.

Forward looking statements were included here that the Company believes to be accurate given the current information. They involve known and unknown risks, uncertainties and other important factors which if changed may affect the outcome(s)